CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,208 | +180.2% | 10,086 | +149.0% | 0.00% | – |
| Q2 2023 | $17,204 | -15.3% | 4,050 | +5.9% | 0.00% | – |
| Q1 2023 | $20,300 | -18.8% | 3,825 | -2.8% | 0.00% | – |
| Q4 2022 | $25,000 | -40.5% | 3,936 | -1.4% | 0.00% | – |
| Q3 2022 | $42,000 | +500.0% | 3,990 | +191.0% | 0.00% | – |
| Q2 2022 | $7,000 | 0.0% | 1,371 | +72.9% | 0.00% | – |
| Q1 2022 | $7,000 | -50.0% | 793 | -11.5% | 0.00% | – |
| Q4 2021 | $14,000 | -33.3% | 896 | +2.2% | 0.00% | – |
| Q3 2021 | $21,000 | – | 877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 674,196 | $6,189,000 | 7.17% |
| 72 Investment Holdings, LLC | 474,067 | $4,352,000 | 4.76% |
| Velan Capital Investment Management LP | 210,695 | $1,934,000 | 1.80% |
| PFM Health Sciences, LP | 4,370,545 | $40,122,000 | 1.50% |
| Monashee Investment Management LLC | 470,000 | $4,315,000 | 1.25% |
| Avidity Partners Management LP | 2,819,067 | $25,879,000 | 0.54% |
| Rokos Capital Management LLP | 849,334 | $7,899,000 | 0.37% |
| Green Alpha Advisors, LLC | 49,674 | $456,000 | 0.31% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 181,304 | $1,664,000 | 0.25% |
| Tekla Capital Management LLC | 699,377 | $6,420,000 | 0.22% |